[Expansion of Review Targets] AI Primary Review Service for Pharmaceutical Materials 'MIRAI Review' Now Supports Web Content, Videos, Patient Materials, and Disease Explanation Materials
A Saga-based IT company has expanded the capabilities of its AI primary review service 'MIRAI Review' for pharmaceutical companies to include web content and videos.
📋 Article Processing Timeline
- 📰 Published: April 13, 2026 at 10:00
- 🔍 Collected: April 13, 2026 at 12:51 (2h 51m after Published)
- 🤖 AI Analyzed: April 19, 2026 at 21:52 (153h 1m after Collected)
It is an IT company founded in Saga in 2005. With the motto 'always new idea.', we constantly provide IT solutions that delight the world. In addition to our Saga headquarters, we have five branches in Sapporo, Tokyo, Osaka, Nagoya, and Fukuoka, as well as 11 of our own studios. Alongside our core businesses of managing and streaming web lectures and researching and developing AI (machine learning / deep learning / generative AI) applications, we are developing various businesses such as esports and the metaverse.